Back to browse

Investigation of enhanced intracellular delivery of nanomaterials modified with novel cell-penetrating zwitterionic peptide-lipid derivatives

Paper ID

PAPER000132

Year

2023

DOI

10.1080/10717544.2023.2191891

PMID

36964673

Journal

Drug Delivery

Source URL

Experiments

• EXP000650 with KK-(EK)4-lipid (none (uptake model))
• EXP000651 with EK-(EK)4-lipid (none (uptake model))
• EXP000652 with K-(EK)4-lipid (none (uptake model))
• EXP000653 with KKK-(EK)4-lipid (none (uptake model))
• EXP000654 with KKKK-(EK)4-lipid (none (uptake model))
• EXP000655 with RR-(EK)4-lipid (none (uptake model))
• EXP000656 with GKK-(EK)4-lipid (none (uptake model))
• EXP000657 with KKG-(EK)4-lipid (none (uptake model))
• EXP000658 with KK-(EK)1-lipid (none (uptake model))
• EXP000659 with KK-(EK)2-lipid (none (uptake model))
• EXP000660 with KK-(EK)3-lipid (none (uptake model))
• EXP000661 with KK-(SG)4-lipid (none (uptake model))